Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Saroja Pharma Industries India Financial Results

Saroja Pharma approved its FY2026 audited financial results, reporting an annual total income of ₹70.24 Crore. The board confirmed an unmodified auditor's opinion on these standalone figures.

Key figures
Value₹70.24 Cr
Source

NSE filing, NSE: SAROJA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Saroja Pharma Industries India Ltd: key numbers

Share price
₹38.80
Market cap
₹15.60 Cr
Revenue (annual)
₹70.13 Cr
Net profit (annual)
₹1.62 Cr
P/E (TTM)
9.6×Sector 34.1×
Promoter holding
73.02%
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Saroja Pharma Industries India Ltd

All →

Other financial results announcements

All →